264 related articles for article (PubMed ID: 33303834)
1. Urinary metabolic phenotyping for Alzheimer's disease.
Kurbatova N; Garg M; Whiley L; Chekmeneva E; Jiménez B; Gómez-Romero M; Pearce J; Kimhofer T; D'Hondt E; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Aarsland D; Nevado-Holgado A; Liu B; Snowden S; Proitsi P; Ashton NJ; Hye A; Legido-Quigley C; Lewis MR; Nicholson JK; Holmes E; Brazma A; Lovestone S
Sci Rep; 2020 Dec; 10(1):21745. PubMed ID: 33303834
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry.
González-Domínguez R; García A; García-Barrera T; Barbas C; Gómez-Ariza JL
Electrophoresis; 2014 Dec; 35(23):3321-30. PubMed ID: 25136972
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations.
Panyard DJ; Kim KM; Darst BF; Deming YK; Zhong X; Wu Y; Kang H; Carlsson CM; Johnson SC; Asthana S; Engelman CD; Lu Q
Commun Biol; 2021 Jan; 4(1):63. PubMed ID: 33437055
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.
Yoshida M; Higashi K; Kuni K; Mizoi M; Saiki R; Nakamura M; Waragai M; Uemura K; Toida T; Kashiwagi K; Igarashi K
Clin Chim Acta; 2015 Feb; 441():115-21. PubMed ID: 25542982
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
Yilmaz A; Geddes T; Han B; Bahado-Singh RO; Wilson GD; Imam K; Maddens M; Graham SF
J Alzheimers Dis; 2017; 58(2):355-359. PubMed ID: 28453477
[TBL] [Abstract][Full Text] [Related]
7. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
[TBL] [Abstract][Full Text] [Related]
8. The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairment.
Ma L; Chen J; Wang R; Han Y; Zhang J; Dong W; Zhang X; Wu Y; Zhao Z
J Clin Neurosci; 2015 Apr; 22(4):649-52. PubMed ID: 25564275
[TBL] [Abstract][Full Text] [Related]
9. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
[TBL] [Abstract][Full Text] [Related]
10. Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS.
Sun C; Gao M; Wang F; Yun Y; Sun Q; Guo R; Yan C; Sun X; Li Y
Biomed Chromatogr; 2020 Sep; 34(9):e4875. PubMed ID: 32384189
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
[TBL] [Abstract][Full Text] [Related]
12. Study on Urine Metabolic Profile of Aβ25-35-Induced Alzheimer's Disease Using UHPLC-Q-TOF-MS.
Liu Y; Wei M; Yue K; Hu M; Li S; Men L; Pi Z; Liu Z; Liu Z
Neuroscience; 2018 Dec; 394():30-43. PubMed ID: 30316910
[TBL] [Abstract][Full Text] [Related]
13. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
[TBL] [Abstract][Full Text] [Related]
14. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
15. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
16. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.
Costa AC; Joaquim HPG; Forlenza OV; Gattaz WF; Talib LL
Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):483-488. PubMed ID: 31218445
[TBL] [Abstract][Full Text] [Related]
17. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
[TBL] [Abstract][Full Text] [Related]
18. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B
J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
Chung JK; Plitman E; Nakajima S; Caravaggio F; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Shinagawa S; Patel R; Chakravarty MM; Graff-Guerrero A;
J Alzheimers Dis; 2017; 58(3):747-762. PubMed ID: 28505977
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
